The pharmaceutical composition of hydrophobicity camptothecin derivative

The pharmaceutical composition of hydrophobicity camptothecin derivative

  • CN 103,957,912 B
  • Filed: 11/02/2012
  • Issued: 04/05/2019
  • Est. Priority Date: 11/03/2011
  • Status: Active Grant
First Claim
Patent Images

1. a kind of pharmaceutical composition, it is characterised in that include:

  • The pharmaceutically acceptable salt of at least one hydrophobicity camptothecin derivative or the derivative;

    WithAt least one polyethylene glycol (PEG) combines phosphatide;

    Wherein described in the PEG combination phosphatide and the hydrophobicity camptothecin derivative or the hydrophobicity camptothecin derivativeThe molar ratio of pharmaceutically acceptable salt is 0.45;

    1 to 1.50;

    1;

    The hydrophobicity camptothecin derivative is the compound selected from the group being made up of;

    TLC388HCl, TLC1988HClWith its mixture,The chemical structural formula of TLC388HCl is

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×